YC S20
Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
About
Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.
Founders
- JONATHAN SPORN
- Andrew Kruegel
- Dalibor Sames
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Gilgamesh Pharmaceuticals.
See family office activityIndustry & Focus
HealthcareDrug Discovery and DeliveryTherapeuticsPsychedelicsMental Health